ConvaTec Group PLC (ConvaTec) is a global medical products and technologies company focused on therapies for managing chronic conditions. The company's main activities include the development and provision of advanced wound care, ostomy care, continence and critical care, and infusion devices. Its major products include wound dressings, skin care products, disposable infusion sets, urological catheters, and devices and accessories for people with ostomy, urinary continence, spinal cord injuries, diabetes, ulcers, multiple sclerosis, spina bifida, and other disorders. ConvaTec offers products to hospitals, home care agencies, pharmacies, insulin pump manufacturers and retail distributors in the home care market directly and through a network of distributors. The company's products serve patients with chronic conditions, their families, caregivers, and healthcare professionals, addressing needs in areas such as diabetes, colorectal cancer, and neurological diseases. The company has a presence in the Americas, Asia Pacific, Europe, the Middle East, and Africa. ConvaTec is headquartered in London, England, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Report Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ConvaTec Group Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- ConvaTec Group Plc Company Overview
- ConvaTec Group Plc Company Snapshot
- ConvaTec Group Plc Pipeline Products and Ongoing Clinical Trials Overview
- ConvaTec Group Plc - Pipeline Analysis Overview
- Business Description
- ConvaTec Group Plc - Key Facts
- ConvaTec Group Plc - Major Products and Services
- ConvaTec Group Plc Pipeline Products by Development Stage
- ConvaTec Group Plc Pipeline Products Overview
- Avelle 2.0
- Avelle 2.0 Product Overview
- Closed Loop Continuous Glucose Monitoring System
- Closed Loop Continuous Glucose Monitoring System Product Overview
- ConvaNiox
- ConvaNiox Product Overview
- ConvaVac
- ConvaVac Product Overview
- Esteem 2.0
- Esteem 2.0 Product Overview
- Next Generation Hydrofiber
- Next Generation Hydrofiber Product Overview
- Wound Dressing
- Wound Dressing Product Overview
- ConvaTec Group Plc - Key Competitors
- ConvaTec Group Plc - Key Employees
- ConvaTec Group Plc - Key Employee Biographies
- ConvaTec Group Plc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- ConvaTec Group Plc, Recent Developments
- Nov 17, 2025: Convatec Partners With LTIMindtree for SAP S/4HANA Transformation
- Sep 22, 2025: Convatec Secures Regulatory Approval for Convamatrix in UK and Europe, Supporting More Patients With Pioneering Skin Substitute Technology
- Aug 21, 2025: Observe Medical Has Seen Successful Customer Conversions in Switzerland and Slovenia and Receives Additional Orders
- Jul 24, 2025: Convatec Secures US and European Regulatory Clearance for Aquacel ConvaFiber Wound Care Innovation
- Jul 16, 2025: ConvaTec Receives FDA 510(k) Clearance for Cure Twist Female Catheter
- Jul 15, 2025: Convatec Responds to CMS Draft Payment Proposal for Skin Substitutes in the United States
- Jun 30, 2025: Advancing subcutaneous infusion therapy for patients through innovation and partnerships
- Jun 26, 2025: Convatec Welcomes Regulatory Approval of Subcutaneous Apomorphine Infusion for Advanced Parkinson’s Disease in the US
- Jun 26, 2025: Strong Nordic Presence: UnoMeter Safeti Plus Wins Tenders in Stockholm and Helsinki/Tampere; Footprint Established in Denmark With Continuous Growth
- Jun 19, 2025: Cure Medical Receives Additional FDA 510(k) Clearance for Cure Catheter Hydrophilic Coated
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- ConvaTec Group Plc Pipeline Products and Ongoing Clinical Trials Overview
- ConvaTec Group Plc Pipeline Products by Equipment Type
- ConvaTec Group Plc Pipeline Products by Indication
- ConvaTec Group Plc, Key Facts
- ConvaTec Group Plc, Major Products and Services
- ConvaTec Group Plc Number of Pipeline Products by Development Stage
- ConvaTec Group Plc Pipeline Products Summary by Development Stage
- Avelle 2.0 - Product Status
- Avelle 2.0 - Product Description
- Closed Loop Continuous Glucose Monitoring System - Product Status
- Closed Loop Continuous Glucose Monitoring System - Product Description
- ConvaNiox - Product Status
- ConvaNiox - Product Description
- ConvaVac - Product Status
- ConvaVac - Product Description
- Esteem 2.0 - Product Status
- Esteem 2.0 - Product Description
- Next Generation Hydrofiber - Product Status
- Next Generation Hydrofiber - Product Description
- Wound Dressing - Product Status
- Wound Dressing - Product Description
- ConvaTec Group Plc, Key Employees
- ConvaTec Group Plc, Key Employee Biographies
- ConvaTec Group Plc, Other Locations
- ConvaTec Group Plc, Subsidiaries
- Glossary
- ConvaTec Group Plc Pipeline Products by Equipment Type
- ConvaTec Group Plc Pipeline Products by Development Stage
